Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 161 - 170 of 446 results

First page
Previous page
Next page
Next page

MIRIKIZUMAB

Z7HVY03PHP

Subunit 1 (441) Similarity Search Subunit 2 (441) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (441) Similarity Search Subunit 2 (441) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761279

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761279

First approved in 2023

Source:

BLA761279

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761279

Class:

PROTEIN

Rozanolixizumab

P7186074QC

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (444) Similarity Search Subunit 2 (444) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761286

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761286

First approved in 2023

Source:

BLA761286

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761286

Class:

PROTEIN

SOMATROGON

6D848RA61B

Subunit 1 (275) Similarity Search

Sequence Search

Subunit 1 (275) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761184

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761184

First approved in 2023

Source:

BLA761184

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761184

Class:

PROTEIN

LECANEMAB

12PYH0FTU9

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Sequence Search

Subunit 1 (454) Similarity Search Subunit 2 (454) Similarity Search Subunit 3 (219) Similarity Search Subunit 4 (219) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761269

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269

First approved in 2023

Source:

BLA761269

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761269

Class:

PROTEIN

BIMEKIZUMAB

09495UIM6V

Subunit 1 (455) Similarity Search Subunit 2 (455) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Sequence Search

Subunit 1 (455) Similarity Search Subunit 2 (455) Similarity Search Subunit 3 (214) Similarity Search Subunit 4 (214) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761151

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761151

First approved in 2023

Source:

BLA761151

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761151

Class:

PROTEIN

Velmanase Alfa

M91TG242P2

Subunit 1 (552) Similarity Search Subunit 2 (281) Similarity Search Subunit 3 (129) Similarity Search

Sequence Search

Subunit 1 (552) Similarity Search Subunit 2 (281) Similarity Search Subunit 3 (129) Similarity Search

Status:

US Approved Rx (2023)

Source:

BLA761278

(2023)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761278

First approved in 2023

Source:

BLA761278

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761278

Class:

PROTEIN

Oligopeptide-104

MUM5TLH7X6

Subunit 1 (11) Similarity Search

Sequence Search

Subunit 1 (11) Similarity Search

Status:

Possibly Marketed Outside US

Source:

M021

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03ec09f9-4281-9ccb-e063-6294a90aadd8

First approved in 2023

Source:

M021

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03ec09f9-4281-9ccb-e063-6294a90aadd8

Class:

PROTEIN

Palmitoyl Tetrapeptide-95

MJN3TLA2BW

Subunit 1 (4) Similarity Search

Sequence Search

Subunit 1 (4) Similarity Search

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20e03d5-3c0a-4d36-b05a-ee3300ee7185

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20e03d5-3c0a-4d36-b05a-ee3300ee7185

Class:

PROTEIN

Palmitoyl Tetrapeptide-94

Z6T2ETB7SH

Subunit 1 (4) Similarity Search

Sequence Search

Subunit 1 (4) Similarity Search

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20e03d5-3c0a-4d36-b05a-ee3300ee7185

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b20e03d5-3c0a-4d36-b05a-ee3300ee7185

Class:

PROTEIN

Alpha-2-HS-glycoprotein

B3AM8SX9GW

Subunit 1 (282) Similarity Search Subunit 2 (27) Similarity Search

Sequence Search

Subunit 1 (282) Similarity Search Subunit 2 (27) Similarity Search

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e093b82-2a36-cc0f-e063-6394a90a4d6d

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e093b82-2a36-cc0f-e063-6394a90a4d6d

Class:

PROTEIN

Protein

Protein

Rozanolixizumab

Protein

Protein

Protein

Protein

MUM5TLH7X6
Not a public record

Protein

Oligopeptide-104

MJN3TLA2BW
Not a public record

Protein

Palmitoyl Tetrapeptide-95

Z6T2ETB7SH
Not a public record

Protein

Palmitoyl Tetrapeptide-94

Protein

Alpha-2-HS-glycoprotein

Showing 161 - 170 of 446 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1